B Varet
- Hematology top 2%
- Acute Myeloid Leukemia Research 5
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Blood disorders and treatments 4
-
- Lymphoma Diagnosis and Treatment 9
-
- Viral-associated cancers and disorders 6
-
- Erythrocyte Function and Pathophysiology 5
-
- Hemoglobin structure and function 4
B Varet
41 papers receiving 845 citations
Peers
Comparison fields: 5 of 59
- Hematology 376
- Genetics 222
- Pathology and Forensic Medicine 260
- Immunology 194
- Oncology 227
Countries citing papers authored by B Varet
This map shows the geographic impact of B Varet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Varet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Varet more than expected).
Fields of papers citing papers by B Varet
This network shows the impact of papers produced by B Varet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Varet. The network helps show where B Varet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B Varet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 4 | |
| 2 | 2009 | 31 | |
| 3 | 2009 | 2 | |
| 4 | 2006 | 2 | |
| 5 | 2004 | 1 | |
| 6 | 2004 | 99 | |
| 7 | Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial | 2002 | 2 |
| 8 | Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial | 2001 | 5 |
| 9 | 2001 | 2 | |
| 10 | 2000 | 8 | |
| 11 | 1997 | 24 | |
| 12 | 1996 | 2 | |
| 13 | 1995 | 2 | |
| 14 | 1995 | 1 | |
| 15 | 1993 | 134 | |
| 16 | 1991 | 3 | |
| 17 | 1990 | 11 | |
| 18 | [Spontaneous rupture of the spleen in tricholeucocytic leukemia. 2 cases]. | 1981 | 1 |
| 19 | [In vitro study of erythroblast precursors in Vasquez disease (polycythemia vera). Arguments in favor of a double population of erythroblastic stem cells in the bone marrow]. | 1978 | 2 |
| 20 | 1976 | 7 |
About B Varet
B Varet is a scholar working on Genetics, Hematology, Immunology, Pathology and Forensic Medicine and Oncology, having authored 46 papers that have together received 874 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (6 papers), Erythrocyte Function and Pathophysiology (5 papers), Acute Myeloid Leukemia Research (5 papers), Blood disorders and treatments (4 papers) and Hemoglobin structure and function (4 papers). The work is most often cited by research in Hematology (376 citations), Genetics (222 citations), Pathology and Forensic Medicine (260 citations), Immunology (194 citations) and Oncology (227 citations). B Varet has collaborated with scholars based in France and Morocco. Frequent co-authors include Olivier Hermine, Nicole Brousse, Justin Aubin, D Leboeuf, Muhammad Taher, Frédéric Davi, F Valensi, D. Canioni, Ali G. Turhan and D Fière. Their work appears in journals such as Blood, The Nephron journals/Nephron journals, Journal of Clinical Oncology, Bone Marrow Transplantation and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.